^○Christopher P. Fox¹, Michael Roost Clausen², Pieternella Lugtenburg³, Anna Sureda⁴, Pier Luigi Zinzani⁵, Jun Wu⁶, Laura Finn⁷, Signe Diness Vindeløv⁸, Catherine Thieblemont⁹ (1.Nottingham University Hospitals NHS Trust UK, Nottingham, UK, 2.Vejle Hospital, Vejle, Denmark, 3.On behalf of the HOVON Lymphoma Working Group, Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, Netherlands, 4.Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain, 5.Lymphoma and Chronic Lymphoproliferative Syndromes Unit, Institute of Hematology “L. e A. Seràgnoli,” University of Bologna, Bologna, Italy, 6.AbbVie, North Chicago, IL, USA, 7.Ochsner Medical Center, New Orleans, LA, USA, 8.Genmab A/S, Copenhagen, Denmark, 9.Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France)

^○Toshio Shimizu¹, Benjamin Solomon², Daniel Sw Tan³, Philippe A Cassier⁴, Christophe Dooms⁵, Eric Van Cutsem⁶, Conor E Steuer⁷, Neeltje Steeghs⁸, Martin Schuler⁹, Anas Gazzah¹⁰, Martin Wermke¹¹, Enriqueta Felip¹², Herbert Hf Loong¹³, Maria J De Miguel Luken¹⁴, Ashley Jaeger¹⁵, Kun Xu¹⁶, Xiaoming Cui¹⁶, Heather Burks¹⁵, Anna F Farago¹⁵, Rebecca S Heist¹⁷ (1.National Cancer Center Hospital, Tokyo, Japan, 2.Peter MacCallum Cancer Center, Melbourne, Australia, 3.National Cancer Centre Singapore, Singapore, 4.Centre Léon Bérard, Lyon, France, 5.UZ Leuven University Hospital, Leuven, Belgium, 6.University Hospitals Gasthuisberg, Leuven and KU Leuven, Leuven, Belgium, 7.Winship Cancer Institute of Emory University School of Medicine, Georgia, GA, USA, 8.The Netherlands Cancer Institute, Amsterdam, the Netherlands, 9.West German Cancer Center, University Hospital Essen, Essen, Germany, 10.Institut Gustave Roussy, Villejuif, France, 11.Technical University Dresden, NCT/UCC Early Clinical Trial Unit, Dresden, Germany, 12.Vall d’Hebron University Hospital, Barcelona, Spain, 13.Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, 14.Hospital Universitario HM Sanchinarro, Madrid, Spain, 15.Novartis Institutes for BioMedical Research, Cambridge, MA, USA, 16.Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 17.Massachusetts General Hospital, Boston, MA, USA)

^○Kei Morikawa¹, Hisashi Tanaka², Saori Takata³, Satoshi Watanabe⁴, Kazuma Kishi⁵, Kenzo Soejima⁶, Kyoichi Kaira⁷, Hiroshi Kagamu⁷, Kenichi Yoshimura⁸, Noriyuki Matsutani⁹, Nobuhiko Seki¹⁰ (1.Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2.Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, 3.Department of Respiratory Medicine, Kyorin University School of Medicine, 4.Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, 5.Department of Respiratory Medicine, Toho University Omori Medical Center, 6.Clinical and Translational Research Center, Keio University Hospital, 7.Department of Respiratory Medicine, Saitama Medical University International Medical Center, 8.Medical Center for Translational and Clinical Research, Hiroshima University Hospital, 9.Department of Surgery, Teikyo University Hospital, Mizonokuchi, 10.Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine)

^○Masahiro Yoshioka¹, Masashi Kanai¹, Tomohiro Kondo¹, Keita Fukuyama^1,2, Yoshihiro Yamamoto¹, Koji Yamanoi³, Nobuko Kawaguchi-Sakita¹, Motoo Nomura¹, Akira Yokoyama¹, Osamu Kikuchi¹, Junichi Matsubara¹, Atsushi Yamada¹, Yukiko Mori⁴, Sachiko Minamiguchi⁵, Takahiro Yamada⁶, Shigemi Matsumoto^1,2, Manabu Muto¹ (1.Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan, 2.Department of Real World Data R&D, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3.Department of Gynecology and Obstetrics, Kyoto University Hospital, Kyoto, Japan, 4.Division of Medical Information Technology and Administration Planning, Kyoto University Hospital, Kyoto, Japan, 5.Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 6.Clinical Genetics Unit, Kyoto University Hospital, Kyoto, Japan)

^○Junichi Matsubara¹, Kumi Mukai¹, Hidenori Kage², Katsutoshi Oda², Ryo Kudo³, Sadakatsu Ikeda³, Hiromichi Ebi⁴, Kei Muro⁴, Ryuji Hayashi⁵, Nahomi Tokudome⁶, Nobuyuki Yamamoto⁶, Manabu Muto¹ (1.Department of Clinical Oncology, Kyoto University Hospital, 2.The University of Tokyo Hospital, 3.Tokyo Medical And Dental University Hospital, 4.Aichi Cancer Center, 5.Toyama University Hospital, 6.Wakayama Medical University Hospital)

^○Sadakatsu Ikeda¹, Eri Ishibashi¹, Kei Mori², Naoki Sugiyama², Yasunari Shiokawa², Kimiko Sunami², Toyoe Itano³, Jyunko Yokobori¹, Yamato Yamashita¹, Shoichi Kanayama², Hajime Shingu² (1.Tokyo Medical and Dental University, 2.Canon Medical Systems Cooperation, 3.Clinical trial office, Tohoku University)

^○Takuya Aoki¹, Kimito Yamada², Keigo Amaya², Yuki Saito³, Kayo Adachi², Yoichi Koyama², Takashi Ishikawa⁴, Yasuhiro Suzuki³ (1.Department of Clinical Oncology, Tokyo Medical University Hachioji Medical Center, 2.Department of Breast Surgery, Tokyo Medical University Hachioji Medical Centre, 3.Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 4.Department of Breast Surgery, Tokyo Medical University)

^○Kohei Shitara¹, Deirdre Jill Cohen², Eric Van Cutsem³, Yelena Y. Janjigian⁴, Yung-Jue Bang⁵, Shukui Qin⁶, Zev A. Wainberg⁷, Anran Wang⁸, Natalyn Nicole Hawk⁹, Chie-Schin Shih⁸, Pooja Bhagia⁸, Josep Tabernero¹⁰ (1.National Cancer Center Hospital East, Kashiwa, Japan, 2.Icahn School of Medicine at Mount Sinai, New York, NY, USA, 3.University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium, 4.Memorial Sloan Kettering Cancer Center, New York, NY, USA, 5.Seoul National University College of Medicine, Seoul, South Korea, 6.PLA Cancer Centre of Nanjing, Jinling Hospital, Nanjing, China, 7.Department of Medicine and Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA, 8.Merck & Co., Inc., Kenilworth, NJ, USA, 9.Eisai Inc., Woodcliff Lake, NJ, USA, 10.Vall d’Hebron Hospital Campus and Institute of Oncology, Barcelona, Spain)

^○Masato Takahashi¹, Francois-Clement Bidard², Kevin Kalinsky³, Massimo Cristofanilli⁴, Giampaolo Bianchini⁵, Stephen Chia⁶, Wolfgang Janni⁷, Cynthia Ma⁸, Erica Mayer⁹, Yeon Hee Park¹⁰, Steven Fox¹¹, Xiaochun Liu¹², Andrew Walding¹¹, Cynthia Huang-Bartlett¹², Nicholas Turner¹³ (1.Department of Breast Surgery, NHO Hokkaido Cancer Center, 2.Institut Curie, Paris, France, 3.Emory University, Atlanta, GA, 4.Northwestern University Feinberg School of Medicine, Chicago, IL, 5.IRCCS Ospedale San Raffaele, Milan, Italy, 6.British Columbia Cancer Agency, Vancouver, BC, Canada, 7.University Hospital Ulm, Ulm, Germany, 8.Washington University School of Medicine, St Louis, MO, 9.Dana-Farber Cancer Institute, Boston, MA, 10.Sungkyunkwan University School of Medicine, Seoul, Korea, 11.AstraZeneca, Cambridge, United Kingdom, 12.AstraZeneca, Gaithersburg, MD, 13.Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom)

^○Tatsuya Okuno¹, Mitsuyoshi Tei², Yukihiro Yoshikawa², Masatoshi Nomura², Toshinori Sueda², Tae Matsumura², Hiromichi Miyagaki², Masanori Tsujie², Junichi Hasegawa³, Yusuke Akamaru² (1.Department of Medical Oncology, Osaka Rosai Hospital, 2.Department of Surgery, Osaka Rosai Hospital, 3.Department of Surgery, Kaizuka City Hospital)

^○Yoshiaki Nakamura¹, Tanios S. Bekaii-Saab², Bradley J. Monk³, Alicia F. C. Okines⁴, David M. O'Malley⁵, Paula R. Pohlmann⁶, Martin Reck⁷, Evan Y. Yu⁸, Jorge Ramos⁹, Sherry Tan⁹, Tom Stinchcombe¹⁰ (1.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 2.Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA, 3.Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Phoenix, AZ, USA, 4.The Royal Marsden NHS Foundation Trust, London, United Kingdom, 5.The Ohio State University, The James Comprehensive Cancer Center, Columbus, OH, USA, 6.University of Texas MD Anderson Cancer Center, TX, USA, 7.LungenClinic, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany, 8.Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA, 9.Seagen Inc., Bothell, WA, USA, 10.Duke Cancer Institute, Durham, NC, USA)

^○Satomi Ito^1,2, Nozomi Shinagawa^1,2, Mifua Asaka², Fuminori Hongo^2,3, Atsushi Ishiguro⁴ (1.Nursing Department, Teine Keijinkai Hospital, 2.Education and Research Center, Teine Keijinkai Hospital, 3.Pharmaceutical Department, Teine Keijinkai Hospital, 4.Department of Medical Oncology, Teine Keijinkai Hospital)